These observations suggest that the immune system is exposed to misfolded, phosphorylated and aggregated forms of α-synuclein already in the early stage in the course of the disease and thus impaired antibody-mediated clearance mechanisms may lead to the progression of the pathology in synucleinopathies. The gene discussed is SNCA; the disease is synucleinopathy.